Popular antidepressant 'cancels out' effect of breast cancer drug (The Daily Telegraph, 9 February 2010)

09 Feb 2010


Canadian scientists have shown that taking the antidepressant paroxetine (brand name Seroxat) to relieve the side effects of the breast cancer drug Tamoxifen could result in a higher mortality when compared to those not taking paroxetine. Experts advise against any sudden decisions but recommend a review of the data to clarify the nature of the interaction.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story